ly3300054
Showing 1 - 4 of 4
Solid Tumor, Microsatellite Instability-High (MSI-H) Solid Tumors, Cutaneous Melanoma Trial in Worldwide (LY3300054,
Active, not recruiting
- Solid Tumor
- +4 more
- LY3300054
- +4 more
-
Nashville, Tennessee
- +14 more
Jul 21, 2022
Cancer Trial in Boston (LY3300054, Prexasertib)
Completed
- Cancer
- LY3300054
- Prexasertib
-
Boston, MassachusettsDana Farber Cancer Institute
Apr 13, 2021